Pharmaceutical

STAT+: AdventHealth sues MultiPlan, alleging a ‘cartel’ that underpays out-of-network medical claims

STAT+: AdventHealth sues MultiPlan, alleging a ‘cartel’...

Aug 11, 2023

AdventHealth has sued MultiPlan, alleging the company has worked with health ins...

STAT+: What to know about concerns raised by compounded versions of Novo Nordisk’s Wegovy

STAT+: What to know about concerns raised by compounded...

Aug 11, 2023

Here's what you need to know regarding the concerns raised about compounded vers...

Listen: Your guide to Wegovy’s blockbuster heart study

Aug 11, 2023

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And...

Covid took a toll on heart health — and doctors are still grappling with how to help

Covid took a toll on heart health — and doctors are sti...

Aug 11, 2023

“We’re about to exit this pandemic as even a sicker nation” because of virus-rel...

STAT+: A yogurt drink instead of a colonoscopy? Study uses engineered bacteria to detect cancer

STAT+: A yogurt drink instead of a colonoscopy? Study u...

Aug 11, 2023

Using yogurt to replace a colonoscopy may sound far-fetched, but scientists just...

Pharma budget tightening trickles down to Doximity

Pharma budget tightening trickles down to Doximity

Aug 11, 2023

In the latest edition of STAT's Health Tech newsletter: pharma budget tightening...

STAT+: Pharmalittle: Genentech weighs delaying cancer therapy after drug pricing law; Novo continues to restrict supplies of low-dose Wegovy

STAT+: Pharmalittle: Genentech weighs delaying cancer t...

Aug 11, 2023

CEO says Medicare negotiation could encourage Genentech to slow-walk ovarian can...

STAT+: Anavex, maker of rare disease drug, keeps shifting the goalposts in its clinical trials

STAT+: Anavex, maker of rare disease drug, keeps shifti...

Aug 11, 2023

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial...

STAT+: Novo acquires Inversago for up to $1 billion, spotlighting troubled weight loss approach

STAT+: Novo acquires Inversago for up to $1 billion, sp...

Aug 11, 2023

Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a sma...

STAT+: Where are patients getting their prescriptions for GLP-1 drugs like Wegovy and Ozempic?

STAT+: Where are patients getting their prescriptions f...

Aug 11, 2023

A new analysis suggests telehealth companies could account for nearly half of al...

CD70 CAR-T by UTC Therapeutics for Mantle Cell Lymphoma...

Aug 10, 2023

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Burkitt Lymphoma: Li...

Aug 10, 2023

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Follicular Lymphoma:...

Aug 10, 2023

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Anaplastic Large Cel...

Aug 10, 2023

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for B-Cell Non-Hodgkin L...

Aug 10, 2023

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Relapsed Chronic Lym...

Aug 10, 2023

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...